Does stimulant drug-induced sensitization occur in primates?

Szczegóły
Abstrakt

Tytuł:: Does stimulant drug-induced sensitization occur in primates?
Autorzy:: Leyton M; From the Departments of Psychiatry and Psychology, McGill University; the Department of Neurology & Neurosurgery, Montreal Neurological Institute, McGill University; the Center for Studies in Behavioral Neurobiology, Concordia University; and the Research Unit on Children's Psychosocial Maladjustment, Université de Montréal, Montreal, Que., Canada .
Źródło:: Journal of psychiatry & neuroscience : JPN [J Psychiatry Neurosci] 2022 Apr 13; Vol. 47 (2), pp. E148-E152. Date of Electronic Publication: 2022 Apr 13 (Print Publication: 2022).
Typ publikacji:: Editorial
Język:: English
Imprint Name(s):: Publication: <2000->: Ottawa : Canadian Medical Association
Original Publication: Ottawa, Ont., Canada : Journal of Psychiatry and Neuroscience, 1991-
MeSH Terms:: Central Nervous System Stimulants*/adverse effects
Primates*
Animals ; Behavior, Animal ; Dose-Response Relationship, Drug ; Humans
References:: Eur J Neurosci. 2006 May;23(10):2773-8. (PMID: 16817880)
Sci Rep. 2017 Apr 26;7:46665. (PMID: 28443614)
Neurosci Biobehav Rev. 2019 Dec;107:897-926. (PMID: 31672617)
Biol Psychiatry. 1998 Dec 1;44(11):1171-7. (PMID: 9836021)
Am J Psychiatry. 2021 Jun;178(6):560-571. (PMID: 33397141)
J Neurosci. 2000 Sep 15;20(18):7109-15. (PMID: 10995858)
Nat Rev Neurosci. 2011 Oct 05;12(11):685-700. (PMID: 21971065)
Nat Neurosci. 2018 Nov;21(11):1520-1529. (PMID: 30323276)
Transl Psychiatry. 2021 Sep 1;11(1):445. (PMID: 34471102)
Mol Psychiatry. 2012 Sep;17(9):918-25. (PMID: 21747399)
Behav Pharmacol. 1999 May;10(3):271-81. (PMID: 10780242)
Nat Rev Neurosci. 2016 Jun;17(6):351-65. (PMID: 27150400)
Neuropsychopharmacology. 2013 Aug;38(9):1780-8. (PMID: 23546387)
J Neurosci. 2007 Apr 11;27(15):3998-4003. (PMID: 17428975)
Transl Psychiatry. 2016 Feb 23;6:e740. (PMID: 26905412)
Neuropsychopharmacology. 1999 Jan;20(1):10-28. (PMID: 9885781)
Am J Psychiatry. 2021 May 1;178(5):469. (PMID: 33979542)
Arch Gen Psychiatry. 2006 Dec;63(12):1386-95. (PMID: 17146013)
Biol Psychiatry. 1996 Nov 1;40(9):872-80. (PMID: 8896773)
Neurobiol Stress. 2018 Sep 19;9:151-165. (PMID: 30450381)
Synapse. 1999 Mar 15;31(4):302-8. (PMID: 10051112)
Neuropsychopharmacology. 2020 Apr;45(5):715-716. (PMID: 31969695)
Biol Psychiatry. 1971;3(1):25-32. (PMID: 4999857)
Neuropsychopharmacology. 2000 Jan;22(1):4-13. (PMID: 10633485)
Neurosci Biobehav Rev. 2022 Apr;135:104575. (PMID: 35151770)
N Engl J Med. 2019 Mar 21;380(12):1128-1138. (PMID: 30893533)
Pharmacol Biochem Behav. 1991 Feb;38(2):417-26. (PMID: 2057510)
J Psychiatry Neurosci. 2020 Jun 19;46(1):E1-E13. (PMID: 32559027)
Neuropharmacology. 2009;56 Suppl 1:160-8. (PMID: 18657553)
Sci Rep. 2021 Jun 3;11(1):11667. (PMID: 34083612)
Behav Pharmacol. 2013 Sep;24(5-6):478-81. (PMID: 23903242)
Neuropsychopharmacology. 2013 Aug;38(9):1617-24. (PMID: 23588036)
Brain Res Brain Res Rev. 1991 Sep-Dec;16(3):223-44. (PMID: 1665095)
Science. 2005 Nov 25;310(5752):1340-3. (PMID: 16311338)
Alcohol Clin Exp Res. 2014 Jan;38(1):126-34. (PMID: 23919483)
Addict Biol. 2021 Nov;26(6):e13047. (PMID: 34155732)
Transl Psychiatry. 2019 Feb 15;9(1):93. (PMID: 30770780)
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Nov 15;31(8):1572-92. (PMID: 17904719)
J Neurosci. 2004 Mar 17;24(11):2825-31. (PMID: 15028776)
Biol Psychiatry. 1976 Aug;11(4):403-19. (PMID: 822887)
Neurotoxicol Teratol. 2010 Mar-Apr;32(2):142-51. (PMID: 19737611)
Neurosci Biobehav Rev. 2013 Nov;37(9 Pt A):1999-2014. (PMID: 23333263)
Neuropsychopharmacology. 2021 Aug 12;:. (PMID: 34385608)
J Neurosci. 1996 Feb 15;16(4):1550-60. (PMID: 8778304)
JAMA Netw Open. 2021 May 3;4(5):e218049. (PMID: 33961037)
Neurosci Biobehav Rev. 2004 Jan;27(8):827-39. (PMID: 15019432)
Mol Psychiatry. 2014 Sep;19(9):1037-43. (PMID: 24912491)
J Psychiatry Neurosci. 2016 Aug;41(5):322-30. (PMID: 26900792)
Curr Pharm Des. 2012;18(1):113-8. (PMID: 22236117)
Drug Alcohol Depend. 2016 Mar 1;160:163-9. (PMID: 26832934)
Am J Psychiatry. 2011 Jun;168(6):634-41. (PMID: 21406463)
Neuropsychopharmacology. 2013 Nov;38(12):2385-92. (PMID: 23719505)
Psychopharmacology (Berl). 1982;78(3):245-51. (PMID: 6130556)
Pharmacol Biochem Behav. 1990 Feb;35(2):367-72. (PMID: 2320644)
Acta Pharmacol Sin. 2007 Apr;28(4):473-83. (PMID: 17376286)
Pharmacol Biochem Behav. 1981 Feb;14(2):159-63. (PMID: 7208558)
Am Psychol. 2016 Nov;71(8):670-679. (PMID: 27977239)
Biol Psychiatry. 1975 Feb;10(1):3-16. (PMID: 804330)
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Nov 15;31(8):1601-13. (PMID: 17888557)
J Psychiatry Neurosci. 2014 Sep;39(5):291-3. (PMID: 25162147)
Neuropsychopharmacology. 2006 Dec;31(12):2716-27. (PMID: 16971900)
Lancet. 1975 Feb 15;1(7903):409-10. (PMID: 46570)
Neuropsychopharmacology. 2001 Oct;25(4):548-54. (PMID: 11557168)
Addict Biol. 2013 Nov;18(6):985-92. (PMID: 22129527)
Brain Res. 1992 Apr 24;578(1-2):235-43. (PMID: 1380862)
Biol Psychiatry. 2009 May 15;65(10):846-50. (PMID: 19249751)
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Nov 15;31(8):1625-38. (PMID: 17936462)
Neurosci Res. 2015 Dec;101:1-5. (PMID: 26232153)
Synapse. 2003 Sep 15;49(4):226-31. (PMID: 12827641)
Psychopharmacology (Berl). 2000 Aug;151(2-3):99-120. (PMID: 10972458)
J Psychiatry Neurosci. 2021 Jan 21;46(1):E184-E185. (PMID: 33497168)
Trends Pharmacol Sci. 2014 Jun;35(6):268-76. (PMID: 24794705)
Neuropsychopharmacology. 2021 Oct 13;:. (PMID: 34645982)
Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3147-58. (PMID: 18640921)
Transl Psychiatry. 2020 Jan 8;10(1):2. (PMID: 32066718)
Neuropsychopharmacology. 2016 Dec;41(13):2994-3002. (PMID: 27353309)
Mol Psychiatry. 2014 Dec;19(12):1305-13. (PMID: 24322203)
Am J Psychiatry. 1975 Jan;132(1):33-8. (PMID: 45537)
J Neurosci. 2006 Jun 14;26(24):6583-8. (PMID: 16775146)
Neuropsychopharmacology. 2012 Nov;37(12):2566-79. (PMID: 22805599)
Am J Psychiatry. 2018 Aug 1;175(8):729-740. (PMID: 29690790)
Trends Neurosci. 2021 Jul;44(7):516-526. (PMID: 33892963)
J Neurosci. 2005 Apr 13;25(15):3932-9. (PMID: 15829645)
Biol Psychiatry. 1979 Oct;14(5):753-65. (PMID: 115505)
Eur J Pharmacol. 2009 Apr 1;607(1-3):91-5. (PMID: 19232339)
Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91. (PMID: 8401595)
Neuroimage Clin. 2021;31:102695. (PMID: 34015673)
Nature. 1997 Apr 24;386(6627):830-3. (PMID: 9126741)
Biol Psychiatry. 2003 Jul 15;54(2):105-10. (PMID: 12873799)
Neuropsychopharmacology. 2012 Nov;37(12):2555-65. (PMID: 22805600)
Arch Gen Psychiatry. 2011 Jun;68(6):545-54. (PMID: 21300940)
Substance Nomenclature:: 0 (Central Nervous System Stimulants)
Entry Date(s):: Date Created: 20220414 Date Completed: 20220415 Latest Revision: 20220716
Update Code:: 20240105
PubMed Central ID:: PMC9259430
DOI:: 10.1503/jpn.220055
PMID:: 35418507
: Opinia redakcyjna

Competing Interests: Competing interests: None declared.

Informacja